Search Results - "Comas, R"

Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer by Serna, G., Ruiz-Pace, F., Hernando, J., Alonso, L., Fasani, R., Landolfi, S., Comas, R., Jimenez, J., Elez, E., Bullman, S., Tabernero, J., Capdevila, J., Dienstmann, R., Nuciforo, P.

“…Accumulating evidence has identified Fusobacterium as an important pathogenic gut bacterium associated with colorectal cancer. Nevertheless, only limited data…”
Get full text

Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments by Ros, J., Matito, J., Villacampa, G., Comas, R., Garcia, A., Martini, G., Baraibar, I., Saoudi, N., Salvà, F., Martin, Á., Antista, M., Toledo, R., Martinelli, E., Pietrantonio, F., Boccaccino, A., Cremolini, C., Dienstmann, R., Tabernero, J., Vivancos, A., Elez, E.

“…Combination of a BRAF inhibitor (BRAFi) and an anti-epidermal growth factor receptor (EGFR), with or without a MEK inhibitor (MEKi), improves survival in…”
Get full text

Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins by Serra-Pladevall, J., Barberá, M. J., Rodriguez, S., Bartolomé-Comas, R., Roig, G., Juvé, R., Andreu, A.

“…The aims of this study were to determine the antimicrobial susceptibility of Neisseria gonorrhoeae (NG) in our area, to analyze the molecular mechanisms…”
Get full text

Differences in Neisseria gonorrhoeae population structure and antimicrobial resistance pattern between men who have sex with men and heterosexuals by SERRA-PLADEVALL, J., BARBERÁ, M. J., CALLARISA, A. E., BARTOLOMÉ-COMAS, R., ANDREU, A.

“…This study compared the antimicrobial susceptibility and genotypes of strains of Neisseria gonorrhoeae isolated from men who have sex with men (MSM) and from…”
Get full text

CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors by Wang, X, Wang, G, Shi, J, Aa, J, Comas, R, Liang, Y, Zhu, H-J

“…The aim of the study was to determine the effect of carboxylesterase 1 (CES1) genetic variation on the activation of angiotensin-converting enzyme inhibitor…”
Get full text

Combination Strategies for Semantic Role Labeling by Surdeanu, M., Marquez, L., Carreras, X., Comas, P. R.

“…This paper introduces and analyzes a battery of inference models for the problem of semantic role labeling: one based on constraint satisfaction, and several…”
Get full text

Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994–2013) by Roca-Barceló, A., Viñas, G., Pla, H., Carbó, A., Comas, R., Izquierdo, Á., Pinheiro, P. S., Vilardell, L., Solans, M., Marcos-Gragera, R.

“…Purpose We aim to comprehensively describe the incidence and mortality trends of ductal carcinoma in situ (DCIS) in the Girona province, Spain (1994–2013) and…”
Get full text

Suposiciones de la "evaluación externa-estímulos económicos" al profesorado universitario: Método de contraste España-México by Lastra, Rosalía, Comas, Óscar, Aguayo, Eva

“…En este artículo analizamos los efectos instituyentes de la política pública de "evaluación externa-estímulos económicos" aplicada al profesorado universitario…”
Get full text

Necrotizing fasciitis due to community-acquired panton-valentine leukocidin methicillin resistant Staphylococcus aureus by Tobeña Rué, M, Coll Usandizaga, F, García Fontecha, C, Bartolomé Comas, R, Moraga Llop, F A

“…Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) is a worldwide emerging pathogen that is able to produce serious skin and soft- tissue…”
Get full text

CP-051 Comparing the efficacy of afatinib versus erlotinib or gefitinib in non-small cell lung cancer patients by Garcia-Cuevas, L Bravo, Alvarez, P Guillen, Comas, R Medina, Clavo, S Martin, Morera, D Briegas, Mangas, C Meneses, Lobato, E Garcia, Mayoral, JF Rangel

“…BackgroundAfatinib is a second generation irreversible EGFR tyrosine kinase inhibitor (TKI), indicated as firstline therapy in non-small cell lung cancer…”
Get full text

CP-026 Renal safety of tenofovir and cobicistat by Mangas, C Meneses, Comas, R Medina, Morera, D Briegas, Lobato, E Garcia, Galán, C Bonilla, Clavo, S Martin, Mayoral, JF Rangel, García-Cuevas, L Bravo, Gudiño, Y Gonzalez

“…BackgroundThe antiretroviral combination tenofovir disoproxil, emtricitabine, cobicistat and elvitegravir (TDF/FTC/COBI/RVG) has been widely used to treat HIV…”
Get full text

DI-001 Making pharmaceutical care easy by designing interactive software by Morera, D Briegas, Galán, C Bonilla, Mangas, C Meneses, Lobato, E García, Pardal, J, García-Cuevas, LM Bravo, Clavo, S Martín, Comas, R Medina, Mayoral, JF Rangel

“…BackgroundDespite living in the high tech era, there is still a lack of software tools to help pharmacists to carry out their common tasks, pharmaceutical care…”
Get full text

International outbreak of salmonellosis in a hotel in Lloret de Mar, Spain, August 2007 by El Omeiri, N, Puell-Gomez, L, Camps, N, Bartolomé-Comas, R, Simón-Soria, F, Soler-Crespo, P, Martin-Granado, A, Echeita-Sarrionandia, A, Herrera-Guibert, D

Get full text

PD-12 Characterization of best responder patients to oxaliplatin rechallenge in patients with refractory metastatic colorectal cancer (mCRC) by Salva, F., Garcia, A., Saoudi, N., Baraibar, I., Ros, J., Comas, R., Ruiz, F., Rezqallah, A., Cuadra, J., Dientsmann, R., Tabernero, J., Elez, E.

Get full text

626P Mucinous differentiation (MD) as predictor of response in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with BRAF inhibitors (BRAFi) combinations by Ros Montana, F.J., Navarro, V., Comas, R., Landolfi, S., Ramirez, L., Palmer, H.G., Garcia Rodriguez, A., Saoudi Gonzalez, N., Baraibar Argota, I., Rodriguez Castells, M., Salvà Ballabrera, F., Tabernero, J., Elez Fernandez, M.E.

Get full text

P-268 Using 16S rRNA gene sequencing to investigate the composition of Fusobacterium-associated microbiota and its impact on outcome in rectal cancer by Napoli, S., Serna, G., Hernando, J., Ruiz-Pace, F., Alonso, L., Fasani, R., Álvarez, A. García, Landolfi, S., Comas, R., Jimenez, J., Santiago, A., Élez, E., Baraibar, I., Tabernero, J., Dientsmann, R., Capdevila, J., Nuciforo, P.

Get full text

374P Influence of sex on safety and efficacy in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with encorafenib-cetuximab +/-binimetinib (E-C+/-B) by Ros Montana, F.J., Navarro, V., Comas, R., Garcia Rodriguez, A., Gomez, D., Saoudi Gonzalez, N., Vicente, P., Cuadra, J.L., Paez, D., Alonso, V., Hernandez Martinez, A., López Valbuena, D.E., Baraibar Argota, I., Salvà Ballabrera, F., Tabernero, J., Elez Fernandez, M.E.

Get full text

TweetNorm: a benchmark for lexical normalization of Spanish tweets by Algeria, Iñaki, Aranberri, Nora, Comas, Pere R., Fresno, Víctor, Gamallo, Pablo, Padró, Lluis, San Vicente, Iñaki, Turmo, Jordi, Zubiaga, Arkaitz

“…The language used in social media is often characterized by the abundance of informal and non-standard writing. The normalization of this non-standard language…”
Get full text

2314P Quality and safety of research biopsies (RB) in oncology clinical trials by Nuciforo, P.G., Ruiz-Pace, F., Jimenez, J., Comas, R., Fasani, R., Viaplana, C., Sevillano, C., Martinez, P., Créixams, X. Serres, Manich, C. Saura, Fernandez, M.E. Elez, Oaknin, A., Braña, I., Couselo, E. Muñoz, Macarulla, T., Galceran, J. Carles, Tabernero, J., Felip, E., Garralda, E., Dienstmann, R.

Get full text

445P Tumor load surrogates as major prognostic factors in BRAF-V600E mutated (mt) colorectal (CRC) patients treated with BRAF inhibitor+antiEGFR +/- MEK inhibitor by Montana, F.J. Ros, Martini, G., Javierre, G. Villacampa, Baraibar, I., Comas, R., Garcia, A., Salva, F., Gonzalez, N. Saoudi, Ciardiello, D., Toledo, R.D.A., Martinelli, E., Ciardiello, F., Vivancos, A., Palmer, H.G., Dienstmann, R., Tabernero, J., Fernandez, M.E. Elez

Get full text